DOCEAQUALIP 20MG INJECTION contains Docetaxel which belongs to the group of medicines called Taxoids. DOCEAQUALIP 20MG INJECTION is used in the management of breast cancer, special forms of lung cancer (non-small cell lung cancer), prostate cancer, gastric (stomach) cancer and/or head and neck cancer in affected individuals.
DOCEAQUALIP 20MG INJECTION is not recommended for use in patients who are allergic to docetaxel. It is not recommended for use in patients with low number of white blood cells and in patients suffering from severe liver disease.
Before receiving DOCEAQUALIP 20MG INJECTION, inform your doctor if you are alcohol dependent, and/or suffering from epilepsy, heart and/or kidney disease.
DOCEAQUALIP 20MG INJECTION is not recommended for use during pregnancy unless it is clearly necessary. Women of child-bearing potential should use effective contraception method to avoid getting pregnant while receiving DOCEAQUALIP 20MG INJECTION. The medicine is also not recommended for use in breastfeeding women.
DOCEAQUALIP 20MG INJECTION should be used with caution in children and adolescents (aged below 18 years) which is also advised to be used with caution in elderly patients (aged above 65 years) after consulting the doctor.
The most common side effects of receiving DOCEAQUALIP 20MG INJECTION are infection, hair loss, headache, loss of appetite, indigestion, nausea, vomiting, and/or constipation. Consult your doctor if any of these symptoms worsen.
No content available
